Coronary artery disease and Helicobacter pylori infection: Should we consider eradication therapy as cardiovascular prevention strategy?

International Journal of Cardiology

Volumn 223, Issue , 2016, Pages 711-712

  Zuin, Marco ^a,b   Rigatelli, Gianluca ^a   Del Favero, Giuseppe ^a   Picariello, Claudio ^a   Meggiato, Tamara ^a   Conte, Luca ^a   Faggian, Giuseppe ^c   Zuliani, Giovanni ^b   Roncon, Loris ^a  

^a ROVIGO GENERAL HOSPITAL   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

Cardiovascular prevention; Coronary artery disease; Helicobacter pylori

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; CLOPIDOGREL; ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; RABEPRAZOLE; ANTIINFECTIVE AGENT;

ACUTE HEART INFARCTION; ANTIBIOTIC RESISTANCE; ARTICLE; CAGA GENE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CONTROL STRATEGY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE CONTROL; DRUG CHOICE; ERADICATION THERAPY; GENE; GENE EXPRESSION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RISK REDUCTION; COMPLICATION; HELICOBACTER INFECTIONS; ISOLATION AND PURIFICATION; PRACTICE GUIDELINE;

ANTI-BACTERIAL AGENTS; CORONARY ARTERY DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 84983627437     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.08.320     Document Type: Article

References (10)

1. [1] Tan, H.J., Goh, K.L., Extragastrointestinal manifestations of Helicobacter pylori infection: facts or myth? A critical review. J. Dig. Dis. 13 (2012), 342–349.
2. [2] Niccoli, G., Franceschi, F., Cosentino, N., Giupponi, B., De Marco, G., Merra, G., Conte, M., Montone, R.A., Ferrante, G., Bacà, M., Gasbarrini, A., Silveri, N.G., Crea, F., Coronary atherosclerotic burden in patients with infection by CagA-positive strains of Helicobacter pylori. Coron. Artery Dis. 21 (2010), 217–221.
3. [3] Izadi, M., Fazel, M., Sharubandi, S.H., Saadat, S.H., Farahani, M.M., Nasseri, M.H., Dabiri, H., SafiAryan, R., Esfahani, A.A., Ahmadi, A., Jonaidi Jafari, N., Ranjbar, R., Jamali-Moghaddam, S.R., Kazemi-Saleh, D., Kalantar-Motamed, M.H., Taheri, S., Helicobacter species in the atherosclerotic plaques of patients with coronary artery disease. Cardiovasc. Pathol. 21 (2012), 307–311.
4. [4] Liu, J., Wang, F., Shi, S., Helicobacter pylori infection increase the risk of myocardial infarction: a meta-analysis of 26 studies involving more than 20,000 participants. Helicobacter 20 (2015), 176–183.
5. [5] Pellicano, R., Parravicini, P.P., Bigi, R., Gandolfo, N., Aruta, E., Gai, V., Figura, N., Angelino, P., Rizzetto, M., Ponzetto, A., Infection by Helicobacter pylori and acute myocardial infarction. Do cytotoxic strains make a difference?. New Microbiol. 25 (2002), 315–321.
6. [6] Figura, N., Palazzuoli, A., Vaira, D., Campagna, M., Moretti, E., Iacoponi, F., Giordano, N., Clemente, S., Nuti, R., Ponzetto, A., Cross-sectional study: CagA-positive Helicobacter pylori infection, acute coronary artery disease and systemic levels of B-type natriuretic peptide. J. Clin. Pathol. 67 (2014), 251–257.
7. [7] Franceschi, F., Niccoli, G., Ferrante, G., Gasbarrini, A., Baldi, A., Candelli, M., Feroce, F., Saulnier, N., Conte, M., Roccarina, D., Lanza, G.A., Gasbarrini, G., Gentiloni, S.N., Crea, F., CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases. Atherosclerosis 202 (2009), 535–542.
8. [8] Vijayvergiya, R., Vadivelu, R., Role of Helicobacter pylori infection in pathogenesis of atherosclerosis. World J. Cardiol. 7 (2015), 134–143.
9. [9] Kowalski, M., Konturek, P.C., Pieniazek, P., Karczewska, E., Kluczka, A., Grove, R., Kranig, W., Nasseri, R., Thale, J., Hahn, E.G., Konturek, S.J., Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty. Dig. Liver Dis. 33 (2001), 222–299.
10. [10] Budzyński, J., The favourable effect of Helicobacter pylori eradication therapy in patients with recurrent angina-like chest pain and non-responsive to proton pump inhibitors — a preliminary study. Arch. Med. Sci. 7 (2011), 73–80.